Qualitative study to explore the acceptability of an accelerated syncope strategy to patients and staff involved in the ASPIRED trial
  The BHF funded ASPIRED study aims to determine whether immediate, enhanced (14-day) ambulatory ECG monitoring decreases the number of episodes of syncope at one year compared to standard care monitoring in ED patients presenting acutely with unexplained syncope. This proposed embedded qualitative study will aim to explore the acceptability of an accelerated syncope strategy health professionals, and to explore patient’s concerns, worries, expectations and wishes and how these interact with patients’ acceptability of the ASPIRED accelerated syncope strategy. We will recruit around 20 patients and 20 healthcare professionals from from 4 National Health Service ASPIRED study sites and conduct semi-structured interviews.

  • Start Date:

    1 June 2022

  • End Date:

    14 January 2024

  • Activity Type:

    Externally Funded Research

  • Funder:

    British Heart Foundation

  • Value:

    £17189

Project Team